Traditional Chinese medicine for non-alcoholic fatty liver disease: an overview of systematic reviews with evidence mapping and metabolic outcome assessment

医学 系统回顾 中医药 脂肪肝 梅德林 替代医学 循证医学 疾病 心理干预 临床实习 重症监护医学 荟萃分析 循证实践 临床试验 医学物理学 传统医学 基础(证据) 生物信息学 知识翻译 临床研究设计 精密医学 代谢综合征 肝病 质量评定 中西医结合 肝脏代谢
作者
Juanjuan Li,Ruimin Jiao,Wenquan Su,Wei Chen,Xiangyu Hu,Shuai Xu,Lie Xu,Weiwei Yao,Kejia Liu,Hong You,Jingjie Zhao
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:16: 1675793-1675793 被引量:5
标识
DOI:10.3389/fphar.2025.1675793
摘要

The paradigm shift from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) emphasizes metabolic pathogenesis, yet the efficacy of Traditional Chinese Medicine (TCM) under this framework remains unevaluated. Prior reviews focused on NAFLD with outdated data (<2020), lacking clinical translation tools and methodological standards for TCM systematic reviews and meta-analyses (SRs/MAs). This overview integrates NAFLD criteria, visualizes TCM efficacy via evidence mapping, proposes a methodological framework to standardize TCM SRs/MAs, and focuses on evaluating metabolism-related indicators. Nine databases were searched (from database inception to December 30, 2024) for TCM SRs/MAs in NAFLD. Methodological quality was assessed via AMSTAR-2, PRISMA/PRISMA-CHM, and GRADE. Evidence mapping visualized outcomes (liver enzymes, metabolism) to identify clinical priorities. Standardized reporting guidelines for TCM preparations were adhered to, and a ConPhYMP tool assessment evaluated botanical drugs composition and processing disclosure. Thirty-seven SRs/MAs (35 low/critically low quality) reported trends of reduced ALT (-8.2 U/L, 95% CI: -10.1 to -6.3), improved metabolic parameters (e.g., TG: -0.5 mmol/L), and enhanced B-ultrasound resolution (RR: 1.62), though these findings are limited by methodological flaws and low-quality evidence. Evidence mapping highlighted Xiaoyao Powder and Danning Tablet as top-performing formulas. A methodological framework addressing TCM heterogeneity (formula standardization, dosage) and reporting biases was proposed. This is the first overview integrating NAFLD criteria to visualize TCM-related evidence, offering preliminary observations on potential associations between TCM interventions and metabolic outcomes in NAFLD (interpreted with caution due to low evidence quality). The evidence map and methodological guidelines provide a foundation for standardized future TCM research, while clinical translation of current findings is not recommended due to insufficient high-quality evidence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
bkagyin的应助被虚心的冷雁采纳,获得10
1秒前
2秒前
2秒前
W1ndyKnight发布了新的文献求助10
2秒前
失落完成签到 ,获得积分20
2秒前
坚定的夜南完成签到,获得积分10
3秒前
3秒前
3秒前
Reina发布了新的文献求助10
3秒前
4秒前
91hkw完成签到,获得积分10
5秒前
荼蘼发布了新的文献求助10
5秒前
nenenn发布了新的文献求助10
7秒前
蓬莱第几宫完成签到,获得积分10
7秒前
小小小乐完成签到 ,获得积分10
8秒前
8秒前
罗小黑发布了新的文献求助10
8秒前
Owen的应助被谢伊代采纳,获得10
8秒前
dzy完成签到,获得积分10
10秒前
11秒前
Akim的应助被老年学术废物采纳,获得10
11秒前
12秒前
12秒前
Heloise完成签到,获得积分10
12秒前
卡夫卡的熊完成签到 ,获得积分10
13秒前
Capricorn完成签到 ,获得积分10
13秒前
水牛完成签到,获得积分10
14秒前
橡木wll完成签到,获得积分10
14秒前
Orange的应助被舒心的乌龟采纳,获得10
15秒前
斯多姆发布了新的文献求助10
15秒前
隐形曼青的应助被张兆阳采纳,获得10
16秒前
zzy完成签到 ,获得积分10
16秒前
小汪快跑完成签到 ,获得积分10
17秒前
爆米花的应助被mkbk采纳,获得10
17秒前
荼蘼发布了新的文献求助10
17秒前
地雷完成签到 ,获得积分10
19秒前
高贵飞丹发布了新的文献求助10
19秒前
梅溪湖的提词器完成签到,获得积分0
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566955
关于积分的说明 21789278
捐赠科研通 7769593
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241